SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-19-001739
Filing Date
2019-01-15
Accepted
2019-01-15 16:02:14
Documents
1
Period of Report
2019-01-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tv511069_4.html 4  
1 OWNERSHIP DOCUMENT tv511069_4.xml 4 7717
  Complete submission text file 0001144204-19-001739.txt   9271
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 6440 WINDERMERE NORTH BETHESDA MD 20852
Business Address
Hu Cynthia W. (Reporting) CIK: 0001364709 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20713 | Film No.: 19527160